Application 208200
- Type
- ANDA
- Sponsor
- INVAGEN PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VILAZODONE HYDROCHLORIDE | VILAZODONE HYDROCHLORIDE | TABLET;ORAL | 10MG | No | No |
| 002 | VILAZODONE HYDROCHLORIDE | VILAZODONE HYDROCHLORIDE | TABLET;ORAL | 40MG | No | No |
| 003 | VILAZODONE HYDROCHLORIDE | VILAZODONE HYDROCHLORIDE | TABLET;ORAL | 20MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 76282-544 | Vilazodone Hydrochloride | Vilazodone Hydrochloride | Exelan Pharmaceuticals Inc. | ANDA | Current |
| 76282-545 | Vilazodone hydrochloride | Vilazodone hydrochloride | Exelan Pharmaceuticals Inc. | ANDA | Current |
| 76282-546 | Vilazodone hydrochloride | Vilazodone hydrochloride | Exelan Pharmaceuticals Inc. | ANDA | Current |